NextCure, Inc. — Director's Dealing 2020

Jun 15, 2020

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: NextCure, Inc. (NXTC)
CIK: 0001661059
Period of Report: 2020-06-11

Reporting Person: Webster Stephen W (Director)

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2020-06-11	Stock Option (Right to Buy)	$24.13	A	14250	Acquired	2030-06-10	Common Stock (14250)	Direct

Footnotes

F1: The option vests in full on the earlier of June 11, 2021 and the date of the 2021 Annual Meeting of Stockholders.